Drug – bio-affecting and body treating compositions – Inorganic active ingredient containing – Alkali or alkaline earth chloride
Patent
1996-10-03
1998-10-27
Azpuru, Carlos A.
Drug, bio-affecting and body treating compositions
Inorganic active ingredient containing
Alkali or alkaline earth chloride
424439, 424 944, 514440, 426 34, A01N 5908
Patent
active
058275444
ABSTRACT:
A method for treatment and prevention of neonatal hyperbilirubinemia by oral administration of a preparation to treat and prevent neonatal hyperbilirubinemia. A preparation that can be used includes castor oil, honey and cellulose fibers. Another preparation that can be used includes castor oil, cellulose fibers, magnesium and vitamin B.sub.2. The magnesium may be in the form of magnesium salts, magnesium oxides or any other form suitable for use in newborns.
REFERENCES:
patent: 4968495 (1990-11-01), Inoue
patent: 5254572 (1993-10-01), Serfontein
patent: 5569670 (1996-10-01), Weischer
patent: 5569675 (1996-10-01), Rephaeli
Abu Seir Husni H.
El-Wadi Bassam M.
Sunnoqrot Wael F.
Azpuru Carlos A.
Faulkner D.
The Arab Pharmaceutical Manufacturing Co. Ltd.
LandOfFree
Different way of management of neonatal hyperbilirubinemia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Different way of management of neonatal hyperbilirubinemia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Different way of management of neonatal hyperbilirubinemia will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1612140